Stability of zonisamide in extemporaneously compounded oral suspensions

American Journal of Health-System Pharmacy

Volumn 66, Issue 12, 2009, Pages 1105-1109

  Abobo, Cyril V ^a   Wei, Bo ^a   Liang, Dong ^a  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

Author keywords

Anticonvulsants; Chromatography, liquid; Compounding; Concentration; Excipients; Methylcellulose; Refrigeration; Stability; Storage; Suspensions; Temperature; Zonisamide

Indexed keywords

METHYLCELLULOSE; ZONISAMIDE;

ARTICLE; CONCENTRATION (PARAMETERS); DRUG CAPSULE; DRUG DETERMINATION; DRUG STABILITY; DRUG SYNTHESIS; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRESCRIPTION; PRIORITY JOURNAL; ROOM TEMPERATURE; SUSPENSION; SYRUP;

EID: 67649622938     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080250     Document Type: Article

References (8)

1. Zonegran (zonisamide capsules) package insert. South San Francisco, CA: Elan Pharma; 2002 Jun 18.
2. Stefan H, Feuerstein TJ. Novel anticonvulsant drugs. Pharmacol Ther. 2007; 113:165-183
3. Malphrus AD, Wilfong AA. Use of the newer antiepileptic drugs in pediatric epilepsies. Curr Treat Options Neurol. 2007; 9:256-267 (Pubitemid 47064609)
4. Chadwick DW, Marson AG. Zonisamide add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev. 2005; 4:CD001416.
5. Fukushima K, Seino M. A long-term follow-up of zonisamide monotherapy. Epilepsia. 2006; 47:1860-1864 (Pubitemid 44730055)
6. Kothare SV, Kaleyias J, Mostofi N et al. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy. Pediatr Neurol. 2006; 34:351-354
7. Moe PG, Benke TA, Bernard TJ. Neurologic and muscular disorders. In: Hay MW Jr, Levin MJ, Sondheimer JM et al., eds. Current diagnosis and treatment in pediatrics. Columbus, OH: McGraw-Hill; 2007:Table 23-112
8. Clinical Pharmacology online [monograph online]. Tampa, FL: Gold Standard; 2008. Updated 2002 Sep. (accessed 2008 Jul 24). Zonisamide.